Home › Funds › Portolan Capital Management, LLC › GENI

Portolan Capital Management, LLC position in GENI

GENIUS SPORTS LIMITED · Consumer Discretionary

Portolan Capital Management, LLC reported holding 7,025,809 shares of GENI (GENIUS SPORTS LIMITED) in its Q2 2026 13F filing — a position valued at US$42.6M, representing 1.59% of its reported portfolio and ranking #12 among its reported holdings. Portolan Capital Management, LLC has disclosed GENI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)7.03M sh
Reported value held$42.58M
Portfolio Weight1.59%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Portolan Capital Management, LLC's GENI position evolved

Portolan Capital Management, LLC first disclosed a stake in GENI in Q3 2023 at 3,112,178 shares (US$16.6M). The position peaked in Q3 2025 at 3,612,811 shares, worth US$44.7M. Across 12 filings, Portolan Capital Management, LLC increased the stake 4 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 7,025,809 shares valued at US$42.6M — an increase of 4,234,791 shares quarter over quarter.. Notable position changes include a 32% increase in Q2 2024 (shares rose 44% over the following quarter), a 39% increase in Q1 2025 (shares rose 4% over the following quarter), a 152% increase in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 3.11M $16.59M New
Q4 2023 2.38M $14.73M Reduce
Q1 2024 2.20M $12.59M Reduce
Q2 2024 2.90M $15.80M Add
Q3 2024 3.17M $24.86M Add
Q4 2024 3.07M $26.55M Reduce
Q1 2025 4.28M $42.86M Add
Q2 2025 4.09M $42.50M Reduce
Q3 2025 3.61M $44.73M Reduce
Q4 2025 2.94M $32.38M Reduce
Q1 2026 2.79M $12.36M Reduce
Q2 2026 7.03M $42.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GENI and 13F data

GENI (GENIUS SPORTS LIMITED) is a Consumer Discretionary company. 24 other funds we track also report a position in GENI — the largest reported positions include Senvest Management, LLC (US$96.2M), GLENVIEW CAPITAL MANAGEMENT, LLC (US$81.8M), SHAPIRO CAPITAL MANAGEMENT LLC (US$59.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GENI

All GENI fund holders →

FAQ

How long has Portolan Capital Management, LLC held GENI?

Portolan Capital Management, LLC has disclosed GENI holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Portolan Capital Management, LLC's current position in GENI?

As of Q2 2026, Portolan Capital Management, LLC holds 7.03M shares of GENI (GENIUS SPORTS LIMITED), valued at $42.58M, representing 1.59% of its reported portfolio and ranking #12.

Has Portolan Capital Management, LLC been buying or selling GENI?

In the latest 13F filing (Q2 2026), Portolan Capital Management, LLC increased its position in GENI. The position peaked in Q3 2025 at 3.61M shares.

Which other funds hold GENI?

Other major institutional holders of GENI include Senvest Management, LLC, GLENVIEW CAPITAL MANAGEMENT, LLC, SHAPIRO CAPITAL MANAGEMENT LLC, among 24 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.